Leigh Baldwin & Co’s Merck MRK Stock Holding History

Leigh Baldwin & Co’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$669K	Sell	5,564 -4	-0.1%	-$462	0.43%	52
2025 Q4	$586K	Sell	5,568 -16,618	-75%	-$1.56M	0.39%	62
2025 Q3	$1.86M	Buy	22,186 +805	+4%	+$66.3K	1.05%	21
2025 Q2	$1.69M	Buy	21,381 +319	+2%	+$25.4K	1.11%	19
2025 Q1	$1.89M	Sell	21,062 -353	-2%	-$33K	1.52%	16
2024 Q4	$2.13M	Buy	+21,415	New	+$2.21M	1.8%	11

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Leigh Baldwin & Co's MRK Position: Q1 2026 in Review

Leigh Baldwin & Co reduced its Merck (MRK) stake by 0.07% in Q1 2026, selling an estimated $462 and leaving 5,564 shares worth $669K. The position accounts for 0.43% of the portfolio, ranked #52.

Leigh Baldwin & Co first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.13M in Q4 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Leigh Baldwin & Co held 5,564 shares of Merck worth $669K as of Q1 2026.
Leigh Baldwin & Co sold 4 Merck shares in Q1 2026, an estimated $462.
Merck made up 0.43% of Leigh Baldwin & Co's portfolio in Q1 2026, its #52 holding.
Leigh Baldwin & Co first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
Leigh Baldwin & Co's Merck position peaked at $2.13M in Q4 2024.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Leigh Baldwin & Co's 13F filing for Q1 2026, filed 20 May 2026.